Pfizer said it will allow generic versions of its experimental antiviral COVID-19 pill to be supplied in 95 countries after it struck a deal with the U.N.-backed Medicines Patent Pool, which will see licenses granted to suitable manufacturers https://t.co/Yh4laAbBxz pic.twitter.com/NOS9AYI4gh— Reuters (@Reuters) November 16, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


